Long-term Trends in Leukemia Subtype Burden in China from 1990 to 2021

A study analyzing the burden of four major leukemia subtypes in China from 1990 to 2021 using Global Burden of Disease data. It includes an estimated 105,670 new leukemia cases in 2021 and projects incidence rates through 2046. The analysis was conducted by Yudi Shangguan and published on figshare in 2026.

Use Cases

• Analyze long-term incidence trends for leukemia subtypes based on age-standardized incidence rates.
• Project future leukemia subtype incidence for public health planning based on Bayesian APC modeling.
• Assess the contribution of risk factors like smoking and high BMI to leukemia burden based on attributable DALYs.
• Compare epidemiological profiles of acute myeloid, chronic myeloid, acute lymphoblastic, and chronic lymphocytic leukemia based on age, period, and cohort effects.

Strengths

• Analysis spans a 31-year period from 1990 to 2021.
• Includes data on four distinct leukemia subtypes: AML, CML, ALL, and CLL.
• Uses multiple analytical methods: Joinpoint regression, age-period-cohort modeling, and Bayesian projection.
• Reports an estimated 105,670 new leukemia cases in China for 2021.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is contained in a DOCX file (14.5 KB), suggesting the primary data may be summarized results rather than raw records.

Provenance

Source

Global Burden of Disease (GBD) 2021 database.

Collection Method

Joinpoint regression, age-period-cohort modeling, and Bayesian APC modeling applied to GBD data.

Time Range

1990 to 2021, with projections to 2046.

Freshness

Last updated 2026-06-04 04:32:09; freshness should be verified.

Geography

China.